monarch 2: overall survival of abemaciclib plus fulvestrant in hr , her2- advanced breast cancer
Published 4 years ago • 849 plays • Length 5:34Download video MP4
Download video MP3
Similar videos
-
5:12
monarch 2: abemaciclib added to fulvestrant shows os benefit in hr /her2- advanced breast cancer
-
4:38
monarch 2: overall survival results from abermaciclib plus fulvestrant in hr her2- advanced bre...
-
5:16
cdk4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in hr-positive/her2-nega...
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
4:19
abemaciclib plus nsai for hr , her2- advanced breast cancer - monarch 3 interim data
-
1:13
overall survival data of the monarch-2 trial in hr /her2- breast cancer
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
1:41
postmonarch: abemaciclib with fulvestrant in pretreated hr /her2- breast cancer
-
5:04
abemaciclib fulvestrant at progression of hr mbc
-
8:39
final overall survival analysis of monarch 1
-
0:53
postmonarche: abemaciclib fulvestrant in hr /her2- mbc following cdk4/6i & endocrine therapy
-
2:58
dr. goetz discusses a secondary analysis of the monarch trials in breast cancer
-
4:45
monarch 3: abemaciclib as initial therapy for patients with hr /her2- advanced breast cancer
-
1:46
comment: monarch 3 trial: abemaciclib for advanced breast cancer
-
3:09
overall survival results from monaleesa-3 study on ribociclib plus fulvestrant in advanced breas...
-
5:10
paloma-3: overall survival (os) with palbociclib plus fulvestrant in hr ,her2_ abc
-
1:57
monarcher: final os results of abemaciclib in hr , her breast cancer
-
1:39
abemaciclib for hr /her2- advanced or metastatic breast cancer
-
10:15
monaleesa-3 os results: fulvestrant/ribociclib in postmenopausal hr /her2- advanced breast cancer